bg
K

Kalvista Pharma (KALV)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Kalvista Pharma (KALV)

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of disease... Read more

  • USD12.24
  • USD12.48
  • USD11.96
  • USD16.88
  • 7.70%
  • --
  • 199.66k
  • 354.13k
  • 455M
  • 7.21
  • 32.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.